| Venous thromboembolism prophylaxis after head and spinal trauma: intermittent pneumatic compression devices versus low molecular weight heparin M Kurtoglu, H Yanar, Y Bilsel, R Guloglu, S Kizilirmak, D Buyukkurt, ... World journal of surgery 28, 807-811, 2004 | 200 | 2004 |
| Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS M Benatar, L Zhang, L Wang, V Granit, J Statland, R Barohn, A Swenson, ... Neurology 95 (1), e59-e69, 2020 | 173 | 2020 |
| International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 126 | 2017 |
| Phase 2 trial of rituximab in acetylcholine receptor antibody-positive generalized myasthenia gravis: the BeatMG study RJ Nowak, CS Coffey, JM Goldstein, MM Dimachkie, M Benatar, JT Kissel, ... Neurology 98 (4), e376-e389, 2022 | 85 | 2022 |
| Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised … V Granit, M Benatar, M Kurtoglu, MD Miljković, N Chahin, G Sahagian, ... The Lancet Neurology 22 (7), 578-590, 2023 | 64 | 2023 |
| Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development S Paganoni, JD Berry, M Quintana, E Macklin, BR Saville, MA Detry, ... Annals of neurology 91 (2), 165-175, 2022 | 60 | 2022 |
| Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases M Benatar, J Wuu, C McHutchison, RB Postuma, BF Boeve, R Petersen, ... Brain 145 (1), 27-44, 2022 | 59 | 2022 |
| An international perspective on preceding infections in Guillain-Barré syndrome: the IGOS-1000 cohort SE Leonhard, AA Van Der Eijk, H Andersen, G Antonini, S Arends, ... Neurology 99 (12), e1299-e1313, 2022 | 46 | 2022 |
| Predicting outcome in Guillain-Barré syndrome: international validation of the modified Erasmus GBS outcome score AY Doets, HF Lingsma, C Walgaard, B Islam, N Papri, A Davidson, ... Neurology 98 (5), e518-e532, 2022 | 35 | 2022 |
| Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity M Benatar, V Granit, PM Andersen, AL Grignon, C McHutchison, ... Brain 145 (10), 3500-3508, 2022 | 27 | 2022 |
| International validation of the erasmus Guillain–Barre syndrome respiratory insufficiency score AY Doets, C Walgaard, HF Lingsma, B Islam, N Papri, Y Yamagishi, ... Annals of neurology 91 (4), 521-531, 2022 | 21 | 2022 |
| Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis K Placek, M Benatar, J Wuu, E Rampersaud, L Hennessy, ... EMBO molecular medicine 13 (1), e12595, 2021 | 19 | 2021 |
| Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches CT McMillan, J Wuu, K Rascovsky, S Cosentino, M Grossman, L Elman, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (7-8), 517-526, 2022 | 18 | 2022 |
| CSF Findings in relation to clinical characteristics, subtype, and disease course in patients with Guillain-Barré syndrome H Al-Hakem, AY Doets, AM Stino, SA Zivkovic, H Andersen, HJ Willison, ... Neurology 100 (23), e2386, 2023 | 14 | 2023 |
| Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values S Arends, J Drenthen, P van den Bergh, H Franssen, RDM Hadden, ... Clinical Neurophysiology 138, 231-240, 2022 | 12 | 2022 |
| Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): a national, cross-sectional study C Zizzi, J Seabury, S Rosero, D Alexandrou, E Wagner, JS Weinstein, ... EClinicalMedicine 55, 2023 | 11 | 2023 |
| Addressing outcome measure variability in myasthenia gravis clinical trials JT Guptill, M Benatar, V Granit, AA Habib, JF Howard Jr, C Barnett-Tapia, ... Neurology 101 (10), 442-451, 2023 | 10 | 2023 |
| Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study P Narayanaswami, DB Sanders, L Thomas, D Thibault, J Blevins, R Desai, ... The Lancet Neurology 23 (3), 267-276, 2024 | 9 | 2024 |
| Yes, we can: Neuromuscular examination by telemedicine. MA Saporta, V Granit, R Lewis, M Benatar Muscle & nerve 62 (6), E83-E85, 2020 | 9 | 2020 |
| Abnormal spontaneous activity on needle electromyography in myasthenia gravis D Kannaditharayil, F Napier, V Granit, P Bieri, S Herskovitz Muscle & nerve 56 (2), E11-E12, 2017 | 9 | 2017 |
